News | November 06, 2023
Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr
Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023
Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023
The company expects that this development could improve the strength of its application to the FDA for new drug approval
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The company reported lifetime high EBIDTA of Rs. 250 crores
Subscribe To Our Newsletter & Stay Updated
